Argenx
ARGX
#447
Rank
โ‚น4.752 T
Marketcap
โ‚น76,314
Share price
0.47%
Change (1 day)
42.73%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚น4.752 Trillion

As of December 2025 Argenx has a market cap of โ‚น4.752 Trillion. This makes Argenx the world's 447th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น4.752 T47.93%
2024โ‚น3.212 T71.02%
2023โ‚น1.878 T8.32%
2022โ‚น1.734 T26.7%
2021โ‚น1.368 T33.48%
2020โ‚น1.025 T109.06%
2019โ‚น490.51 B100.08%
2018โ‚น245.15 B91.51%
2017โ‚น128.01 B
2014โ‚น9.22 B

End of Day market cap according to different sources

On Dec 23rd, 2025 the market cap of Argenx was reported to be:

โ‚น4.632 Trillion
by Nasdaq info icon info icon
โ‚น4.730 Trillion
by CompaniesMarketCap info icon info icon